Gliomas with IDH1/2 mutations display a distinct methylation pattern characterized by DNA hypermethylation of CpG islands, the so called CpG island methylator phenotype (CIMP) [21, 34]. This evidence concerns the gene IDH1 and central nervous system cancer.